About 30,280 people will be diagnosed with multiple myeloma this year. What is this lesser-known illness?
Multiple myeloma is a cancer formed by malignant plasma cells in the bone marrow. Plasma cells help fight infections by making antibodies that recognize and attack germs. Rather than produce helpful antibodies, the cancer cells produce abnormal proteins that can harm other tissues and organs, such as the kidneys.
Dr. Adjai Chari shares the symptoms of this cancer you should know and look out for, along with the latest research on treatments and their effectiveness.
Multiple myeloma is a cancer formed by malignant plasma cells in the bone marrow. Plasma cells help fight infections by making antibodies that recognize and attack germs. Rather than produce helpful antibodies, the cancer cells produce abnormal proteins that can harm other tissues and organs, such as the kidneys.
Dr. Adjai Chari shares the symptoms of this cancer you should know and look out for, along with the latest research on treatments and their effectiveness.
Ajai Chari, MD, is the Director of Clinical Research in the Multiple Myeloma Program and Associate Director of Clinical Research at Cancer Clinical Trials Office at The Tisch Cancer Institute at Mount Sinai and Associate Professor of Medicine, Hematology and Medical Oncology at the Icahn School of Medicine at Mount Sinai.